BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help

Search Results

Documents 1-25 out of 31 found
  Current Search:  peg: 213, intron: 31     

HTML
56%
Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy
Jnl of Viral Hepatitis Sept 2008 T.-M.

Scherzer 1 , K.

Reddy 2 , F.

Wrba 3 , H.

Hofer 1 , K.

Staufer 1 , P.

Steindl-Munda 1 , A.

Gangl 1 and P.

Ferenci 1 1 Department of Internal Medicine III, Division of Gastroenterology and...

National AIDS Treatment Advocacy Project:  Oct 11 2008 9:21AM
Matching: intron
Find similar documents
HTML
100%
Biolex to acquire Locteron commercial rights from OctoPlus
Biolex Therapeutics, Inc has entered into an agreement with OctoPlus NV to acquire OctoPlus' 50 per cent share of commercial rights to the Locteron product candidate for hepatitis C.

Under the agreement, Biolex will take full...

PharmaBiz:  Oct 10 2008 12:49PM
Matching: peg intron
Find similar documents
HTML
56%
AAV vectors for gene delivery to the lung
Title: United States Patent: 7,427,396 Inventors: Arbetman; Alejandra E.

(San Francisco, CA), Lochrie; Michael A.

(Hayward, CA) Assignee: Genzyme Corporation (Framingham, MA) Appl.

No.: 11/143,866 Filed: June 2, 2005 Methods of making...

PharmCast:  Oct 10 2008 7:48PM
Matching: intron
Find similar documents
HTML
56%
The FTO gene and measured food intake in children
Polymorphisms in the obesity-associated gene, FTO, have been linked with sensitivity to satiety in children, indicating FTO may be influencing one of the regulatory drivers underlying food intake.

In this study, we tested the hypothesis...

Nature:  Oct 7 2008 10:22AM
Matching: intron
Find similar documents
HTML
56%
Antibodies binding the TNF related protein, TNF-Y
Title: United States Patent: 7,427,668 Inventors: Gorman; Daniel M.

(Palo Alto, CA) Assignee: Schering Corporation (Kenilworth, NJ) Appl.

No.: 11/090,448 Filed: March 25, 2005 Nucleic acids encoding mammalian, e.g., primate or rodent,...

PharmCast:  Oct 7 2008 4:15AM
Matching: intron
Find similar documents
HTML
56%
GM is Dangerous and Futile
We Need Organic Sustainable Food and Energy Systems Now New genetics research invalidates the science underpinning the $73.5 billon global biotech industry and confirms why genetic modification is futile and dangerous; we must implement...
Institute of Sciences in Society:  Oct 7 2008 12:26AM
Matching: intron
Find similar documents
HTML
56%
G/T Substitution in Intron 1 of the UNC13B Gene Is Associated With Increased Risk of Nephropathy in Patients W
Trgouet DA et al.

- The authors identified a polymorphism in the UNC13B gene associated with nephropathy.

UNC13B mediates apopotosis in glomerular cells in the presence of hyperglycemia, an event occurring early in the development of...

MDLinx:  Oct 3 2008 4:42AM
Matching: intron
Find similar documents
HTML
56%
Fungi Self-Training Gene Prediction Program Developed
FUNGI FUNGUS FUNGAL GENE PREDICT SELF TRAINING MUSHROOM UNSUPERVISED EUKARYOTE BRANCH POINT SITE EXON INTRON DNA GENEMARK GENOME SEQUENCE HIDDEN MARKOV MODEL PROTEIN ASCOMYCOTA BASIDIOMYCOTA ZYGOMYCOTA AB INITIO Contact Information...
Newswise:  Sep 30 2008 1:28PM
Matching: intron
Find similar documents
HTML
56%
New Self-training Gene Prediction Program For Fungi Developed
ScienceDaily (Sep.

29, 2008) Researchers at the Georgia Institute of Technology have developed a computer program that trains itself to predict genes in the DNA sequences of fungi.

Fungi which range from yeast to mushrooms are important...

Science Daily:  Sep 30 2008 9:48AM
Matching: intron
Find similar documents
HTML
56%
Researchers develop new self-training
Researchers at the Georgia Institute of Technology have developed a computer program that trains itself to predict genes in the DNA sequences of fungi.Fungi " which range from yeast to mushrooms " are important for industry and human health,...
Checkbiotech:  Sep 30 2008 11:40AM
Matching: intron
Find similar documents
HTML
56%
New self-training gene prediction program for fungi
Software is a new addition to the family of GeneMark gene prediction programs developed at Georgia Tech Researchers at the Georgia Institute of Technology have developed a computer program that trains itself to predict genes in the DNA...
Huliq.com:  Sep 30 2008 12:28AM
Matching: intron
Find similar documents
HTML
56%
Researchers develop new self-training gene prediction program for fungi
Researchers at the Georgia Institute of Technology have developed a computer program that trains itself to predict genes in the DNA sequences of fungi.

Fungi which range from yeast to mushrooms are important for industry and human health,...

Genetic Engineering News:  Sep 29 2008 3:15PM
Matching: intron
Find similar documents
HTML
56%
Researchers develop new self-training gene prediction program for fungi
Researchers at the Georgia Institute of Technology have developed a computer program that trains itself to predict genes in the DNA sequences of fungi.

Fungi - which range from yeast to mushrooms - are important for industry and human...

EurekAlert!:  Sep 29 2008 2:36PM
Matching: intron
Find similar documents
HTML
56%
Compositions for DNA mediated gene silencing
Title: United States Patent: 7,422,896 Inventors: Wang; Jiwu (San Diego, CA) Assignee: Allele Biotechnology & Pharmaceuticals, Inc.

(San Diego, CA) Appl.

No.: 10/217,564 Filed: August 12, 2002 DNA compositions that mediate gene...

PharmCast:  Sep 27 2008 2:12AM
Matching: intron
Find similar documents
HTML
100%
Vertex Pharmaceutical shares rise on midstage study detail for hepatitis C drug candidate
- 1:23 p.m.

NEW YORK (AP) - Shares of Vertex Pharmaceuticals Inc.

rose Wednesday after the biotechnology company provided details that reaffirmed prior positive study results for its hepatitis C drug candidate telaprevir.

The stock...

Canadian Business Magazine:  Sep 24 2008 5:46PM
Matching: peg intron
Find similar documents
HTML
56%
HCG beta gene variants implicated in recurrent miscarriage
MedWire News: Genetic variants of human chorionic gonadotropin (HCG) beta genes may affect women's risk for recurrent miscarriage, a European case-control study suggests.

HCG beta subunit genes are expressed in blastocysts shortly after...

MedWire News:  Sep 22 2008 1:56PM
Matching: intron
Find similar documents
HTML
56%
Scientists Trace Extensive Networks Regulating Alternative RNA Splicing
ScienceDaily (Sep.

19, 2008) Two professors at Cold Spring Harbor Laboratory (CSHL) have succeeded in tracing intricate biochemical networks involving a class of proteins that enable genes to express themselves in specific tissues at...

Science Daily:  Sep 20 2008 10:15PM
Matching: intron
Find similar documents
HTML
56%
Engineering and optimization of the miR-106b cluster for ectopic expression of multiplexed anti-HIV RNAs
Many microRNAs (miRNAs) are encoded within the introns of RNA Pol II transcripts, often as polycistronic precursors.

Here, we demonstrate the optimization of an intron encoding three endogenous miRNAs for the ectopic expression...

Nature:  Sep 18 2008 12:06PM
Matching: intron
Find similar documents
HTML
56%
Actual Causes of Death in the United States, 2000
Context Modifiable behavioral risk factors are leading causes of mortality in the United States.

Quantifying these will provide insight into the effects of recent trends and the implications of missed prevention opportunities.

Objectives...

Journal of the American Medical Association:  Sep 10 2008 12:28PM
Matching: intron
Find similar documents
HTML
100%
China's Hep C drug market to grow to $150 mn by 2012
Singapore, Sept 9, 2008: The Chinese hepatitis C virus drug market, dominated by conventional and pegylated interferons, will more than double by 2012 from $64 million in 2007 to $150 million in 2012.

Sales of interferons will expand at a...

Bio Spectrum Asia:  Sep 9 2008 6:39AM
Matching: peg intron
Find similar documents
HTML
100%
China's Hepatitis C Virus Drug Market Will Grow to $150 Million by 2012
Increasing Diagnosis Rates Present Opportunities for Western Drug Companies Seeking to Penetrate Market, According to a New Report From Decision Resources WALTHAM, Mass., September 08, 2008 /PRNewswire/ -- Decision Resources, one of the...
Pharma Live:  Sep 8 2008 4:21PM
Matching: peg intron
Find similar documents
HTML
56%
Cumberland Pharmaceuticals Taps Industry Veteran for Key Executive Position
Martin Cearnal appointed Senior Vice President, Commercial DevelopmentNASHVILLE, Tenn., Sept.

3 (HSMN NewsFeed) -- Cumberland Pharmaceuticals Inc.

has appointed industry veteran Martin E.

Cearnal as Senior Vice President, Commercial...

Healthcare Sales & Marketing Network:  Sep 7 2008 5:10PM
Matching: intron
Find similar documents
HTML
56%
Trichoplax genome sequenced -- 'rosetta stone' for understanding evolution
The findings reported in the online edition of the journal Nature show that while Trichoplax has one of the smallest nuclear genomes found in a multi-cellular creature, it contains signature sequences for gene regulation found in more...
Innovations Report:  Sep 7 2008 2:24AM
Matching: intron
Find similar documents
HTML
56%
Cumberland Pharmaceuticals names new SVP of commercial development
In this newly created position Mr Cearnal will be directly involved with Cumberland's commercial strategy and business development initiatives.

During his 40-year healthcare career, Mr Cearnal has been involved with the launches of...

Pharmaceutical Business Review:  Sep 5 2008 11:43AM
Matching: intron
Find similar documents
HTML
56%
Cearnal joins Cumberland Pharmaceuticals in new VP role
Cearnal will be directly involved with Cumberland's commercial strategy and business development initiatives.

He brings extensive pharmaceutical experience to the new role.

He has been involved with the launches of noteworthy...

East Bay Business Journal:  Sep 4 2008 11:31PM
Matching: intron
Find similar documents

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.